Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy
Author(s) -
Do Kyung Kim,
Kyo Chul Koo,
Kwang Suk Lee,
Yoon Soo Hah,
Koon Ho Rha,
Sung Joon Hong,
Byung Ha Chung
Publication year - 2018
Publication title -
journal of korean medical science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.743
H-Index - 66
eISSN - 1598-6357
pISSN - 1011-8934
DOI - 10.3346/jkms.2018.33.e285
Subject(s) - medicine , prostatectomy , prostate cancer , interquartile range , metastasis , biochemical recurrence , prostate specific antigen , urology , proportional hazards model , oncology , stage (stratigraphy) , dissection (medical) , cancer , surgery , paleontology , biology
RARP confers acceptable oncological outcomes for high-risk PCa. Close monitoring beyond 5 years is warranted for early detection of disease progression and for timely adjuvant therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom